Home » All » Stock Forecast » AN2 Therapeutics Inc. Common Stock Forecast

AN2 Therapeutics Inc. Common Stock Forecasts for Tomorrow, Week, Month and 5 Years

Updated: April 22 · 2026 at 07:03 UTC
▲ +4.97%Market Cap $136.58M · Technical analysis Bullish · Focus area Price + volatility

Forecast Summary

TimeframePredicted PricePastHistoricalInsight
Tomorrow$3.86 +1.59%Yesterday$3.77 -0.67%Tomorrow's AN2 Therapeutics Inc. Common Stock (ANTX) setup is anchored to $3.80 and targets $3.86 (+1.59%). The near-term read is upside; watch $3.91 / $3.69 because daily realized volatility is about 8.00%.
Tomorrow's AN2 Therapeutics Inc. Common Stock (ANTX) setup is anchored to $3.80 and targets $3.86 (+1.59%). The near-term read is upside; watch $3.91 / $3.69 because daily realized volatility is about 8.00%.
Week$3.99 +4.95%Last Week$3.72 -2.08%The 7-day AN2 Therapeutics Inc. Common Stock model moves from $3.72 to $3.99 (+4.95%). It gives upside momentum context for this stock, so breaks around $3.91 / $3.69 matter more than a single tick.
The 7-day AN2 Therapeutics Inc. Common Stock model moves from $3.72 to $3.99 (+4.95%). It gives upside momentum context for this stock, so breaks around $3.91 / $3.69 matter more than a single tick.
Month$4.20 +10.54%Last Month$3.63 -4.43%The 1-month AN2 Therapeutics Inc. Common Stock target is $4.20 (+10.54%), compared with the live reference near $3.80. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
The 1-month AN2 Therapeutics Inc. Common Stock target is $4.20 (+10.54%), compared with the live reference near $3.80. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
Year$4.52 +18.93%Last Year$3.50 -7.95%The 1-year AN2 Therapeutics Inc. Common Stock scenario points to $4.52 (+18.93%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
The 1-year AN2 Therapeutics Inc. Common Stock scenario points to $4.52 (+18.93%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
5 Years$5.27 +38.57%5 Years Ago$3.18 -16.20%The 5-year AN2 Therapeutics Inc. Common Stock view is $5.27 (+38.57%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
The 5-year AN2 Therapeutics Inc. Common Stock view is $5.27 (+38.57%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
Tomorrow$3.86 +1.59%
Yesterday$3.77 -0.67%
Tomorrow's AN2 Therapeutics Inc. Common Stock (ANTX) setup is anchored to $3.80 and targets $3.86 (+1.59%). The near-term read is upside; watch $3.91 / $3.69 because daily realized volatility is about 8.00%.
Week$3.99 +4.95%
Last Week$3.72 -2.08%
The 7-day AN2 Therapeutics Inc. Common Stock model moves from $3.72 to $3.99 (+4.95%). It gives upside momentum context for this stock, so breaks around $3.91 / $3.69 matter more than a single tick.
Month$4.20 +10.54%
Last Month$3.63 -4.43%
The 1-month AN2 Therapeutics Inc. Common Stock target is $4.20 (+10.54%), compared with the live reference near $3.80. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
Year$4.52 +18.93%
Last Year$3.50 -7.95%
The 1-year AN2 Therapeutics Inc. Common Stock scenario points to $4.52 (+18.93%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
5 Years$5.27 +38.57%
5 Years Ago$3.18 -16.20%
The 5-year AN2 Therapeutics Inc. Common Stock view is $5.27 (+38.57%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
Risk notice:This forecast is informational only, not financial advice; accuracy depends on volatility, liquidity, macro events, and other external factors.

Price Chart

HistoricalForecastBullishBearish
$4.07$3.96$3.85$3.74$3.621W AgoNow7D F

Technical Analysis

SellNeutralBuy
Bullish
2
Bullish
3
Neutral
0
Bearish

Key Indicators

IndicatorValueSignal
Price$3.80 Mid
Daily Change+4.97% Above
Volatility Cap20.0% Mid
Confidence68% Above
Data Sourcenasdaq-screener Mid

Historical Data

Current$3.80
Daily Change+4.97%
Market Cap$136.58M
Sourcenasdaq-screener
Current$3.80Daily Change+4.97%
Market Cap$136.58MSourcenasdaq-screener

Support & Resistance Levels

$3.69Support 1
$3.80Current
$3.91Resistance 1
i
Support and resistance are estimated from the trusted current price until deeper historical data is available.

Price Milestones

Key levels & historical context
Current$3.80Live reference price
Used as the anchor for generated forecast calculations.
Next Month$4.20Model projection+10.54%
Directional scenario based on capped drift.

Forecast Accuracy

How our model has performed
68%
Directional
Generated market-data forecast
This page uses live catalog market data and conservative volatility caps. It is informational, not financial advice.
📊
Our algorithm is re-calibrated weekly using the latest price action, volatility regime, and indicator signals. Accuracy varies by timeframe — short-term momentum is more reliable than long-term projections.
Short term
68%
Direction confidence
Long term
Lower
Forecast uncertainty rises with horizon

Investment Scenarios

If you invest $1,000 in ANTX today
Bullish Scenario
$3.99
+5.00% from current
Target Price$3.99
ScenarioUpside momentum
Probability60%
Base Scenario
$4.20
+10.54%
Target Price$4.20
ScenarioCapped drift
Probability68%
Bearish Scenario
$3.61
-5.00% from current
Target Price$3.61
ScenarioVolatility drawdown
Probability32%
Basis: Scenario model combines current spot price, recent market direction, and conservative asset-class volatility caps.

Forecast Factors

Market Structure
Price structure reflects the latest momentum regime and support/resistance interaction.
Momentum Bullish · 72/100
24H drift+1.59%
7D drift+4.95%
30D drift+10.54%
Technical Signals
Signals combine RSI, MACD, and moving average stacks to estimate short-term direction.
Mixed — Watching · 50/100
RSIn/a
MACDn/a
MA stackn/a
Macro Context
Rates, dollar strength, and cross-asset risk appetite influence medium-term paths.
Risk-On Tentative · 69/100
1M outlook+10.54%
1Y outlook+18.93%
5Y outlook+38.57%

Frequently Asked Questions

Q What is the AN2 Therapeutics Inc. Common Stock (ANTX) forecast for tomorrow?
Using the latest BeCoin market snapshot (April 22 · 2026 at 07:03 UTC), AN2 Therapeutics Inc. Common Stock is projected near $3.86 versus the current reference around $3.80. That implies a modeled move of +1.59% over the next day, with realized prices still sensitive to intraday volatility.
Q What does the 7-day stock outlook suggest for ANTX?
The weekly AN2 Therapeutics Inc. Common Stock model points to $3.99, which maps to an expected drift of +4.95% from current conditions. This horizon reacts quickly to momentum shifts, so support/resistance breaks can change the path faster than long-term targets.
Q How should I read the AN2 Therapeutics Inc. Common Stock 1-month and 1-year targets?
The AN2 Therapeutics Inc. Common Stock 1-month target is $4.20 (+10.54%), while the 1-year target is $4.52 (+18.93%). The monthly view tracks prevailing trend pressure, and the yearly view reflects broader cycle assumptions shaped by price momentum, liquidity, and company-specific risk.
Q Why does the AN2 Therapeutics Inc. Common Stock 5-year scenario differ from short-term rows?
The AN2 Therapeutics Inc. Common Stock long-horizon scenario sits near $5.27 with a modeled change of +38.57%. It compounds cycle-continuation assumptions over time, so it should be treated as a scenario envelope rather than a precise endpoint.
Q Where are ANTX support and resistance zones right now?
For AN2 Therapeutics Inc. Common Stock, nearest resistance is around $3.69, while nearest support is around $3.91. A clean break above resistance improves continuation odds, while repeated closes under support raise downside risk.
Q How fresh is the AN2 Therapeutics Inc. Common Stock market snapshot?
The displayed stock snapshot is labeled April 22 · 2026 at 07:03 UTC; the latest observed session range is roughly n/a to n/a. These checkpoints are rebuilt from the market feed so the FAQ, milestones, and support/resistance context stay tied to the same data refresh.
AN2 Therapeutics Inc. Common Stock Forecast 2026 – Tomorrow, Week & Month